Unichem Laboratories Limited (UNICHEMLAB.BO)
INR 610.5
(7.42%)
INR 610.5
(7.42%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 16.57 Billion INR | 30.9% |
| 2022 | 13.02 Billion INR | 4.36% |
| 2021 | 12.47 Billion INR | 4.88% |
| 2020 | 11.89 Billion INR | 13.37% |
| 2019 | 10.49 Billion INR | -6.52% |
| 2018 | 11.22 Billion INR | 44.93% |
| 2017 | 7.74 Billion INR | 15.11% |
| 2016 | 6.73 Billion INR | -49.5% |
| 2015 | 13.32 Billion INR | 10.89% |
| 2014 | 12.01 Billion INR | 6.03% |
| 2013 | 11.33 Billion INR | 4.87% |
| 2012 | 10.8 Billion INR | 23.45% |
| 2011 | 8.75 Billion INR | 6.24% |
| 2010 | 8.24 Billion INR | 10.26% |
| 2009 | 7.47 Billion INR | 1.65% |
| 2008 | 7.35 Billion INR | 9.52% |
| 2007 | 6.71 Billion INR | 6.91% |
| 2006 | 6.27 Billion INR | 14.74% |
| 2005 | 5.47 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 4.46 Billion INR | 3.41% |
| 2023 Q4 | 4.31 Billion INR | -0.62% |
| 2023 FY | 17.04 Billion INR | 30.9% |
| 2023 Q1 | 4.23 Billion INR | 17.06% |
| 2023 Q2 | 4.15 Billion INR | -1.79% |
| 2023 Q3 | 4.34 Billion INR | 4.51% |
| 2022 Q4 | 3.61 Billion INR | 19.51% |
| 2022 Q1 | 3.09 Billion INR | -11.06% |
| 2022 Q2 | 3.28 Billion INR | 6.2% |
| 2022 Q3 | 3.02 Billion INR | -8.01% |
| 2022 FY | 13.02 Billion INR | 4.36% |
| 2021 Q3 | 3.11 Billion INR | 7.1% |
| 2021 FY | 12.47 Billion INR | 4.88% |
| 2021 Q4 | 3.48 Billion INR | 11.82% |
| 2021 Q2 | 2.9 Billion INR | -2.43% |
| 2021 Q1 | 2.97 Billion INR | 30.15% |
| 2020 Q2 | 3.17 Billion INR | 0.09% |
| 2020 Q3 | 3.26 Billion INR | 2.76% |
| 2020 Q4 | 2.28 Billion INR | -29.85% |
| 2020 Q1 | 3.17 Billion INR | 19.21% |
| 2020 FY | 11.89 Billion INR | 13.37% |
| 2019 Q4 | 2.66 Billion INR | -3.18% |
| 2019 Q3 | 2.74 Billion INR | 2.5% |
| 2019 Q2 | 2.68 Billion INR | -1.85% |
| 2019 Q1 | 2.73 Billion INR | -13.99% |
| 2019 FY | 10.49 Billion INR | -6.52% |
| 2018 FY | 11.22 Billion INR | 44.93% |
| 2018 Q4 | 3.17 Billion INR | 4.89% |
| 2018 Q3 | 3.02 Billion INR | 15.96% |
| 2018 Q2 | 2.61 Billion INR | 8.29% |
| 2018 Q1 | 2.41 Billion INR | 20.07% |
| 2017 FY | 7.74 Billion INR | 15.11% |
| 2017 Q4 | 2 Billion INR | 0.0% |
| 2016 Q4 | 10.08 Billion INR | 0.0% |
| 2016 FY | 6.73 Billion INR | -49.5% |
| 2015 FY | 13.32 Billion INR | 10.89% |
| 2014 FY | 12.01 Billion INR | 6.03% |
| 2013 FY | 11.33 Billion INR | 4.87% |
| 2012 FY | 10.8 Billion INR | 23.45% |
| 2011 FY | 8.75 Billion INR | 6.24% |
| 2010 FY | 8.24 Billion INR | 10.26% |
| 2009 FY | 7.47 Billion INR | 1.65% |
| 2008 FY | 7.35 Billion INR | 9.52% |
| 2007 FY | 6.71 Billion INR | 6.91% |
| 2006 FY | 6.27 Billion INR | 14.74% |
| 2005 FY | 5.47 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Bajaj HealthCare Limited | 4.73 Billion INR | -250.096% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 27.409% |
| Hester Biosciences Limited | 3.04 Billion INR | -444.225% |
| Lupin Limited | 200.1 Billion INR | 91.717% |
| Medicamen Biotech Limited | 1.79 Billion INR | -824.35% |
| Medico Remedies Limited | 1.44 Billion INR | -1043.671% |
| NATCO Pharma Limited | 40.02 Billion INR | 58.585% |
| Achyut Healthcare Limited | 61.36 Million INR | -26907.383% |
| Ajanta Pharma Limited | 42.08 Billion INR | 60.619% |
| Alkem Laboratories Limited | 126.67 Billion INR | 86.916% |
| Alpa Laboratories Limited | 1.08 Billion INR | -1424.215% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 72.883% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -27.933% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 94.226% |
| Brooks Laboratories Limited | 794.86 Million INR | -1985.165% |
| Divi's Laboratories Limited | 78.45 Billion INR | 78.873% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 94.063% |
| Eris Lifesciences Limited | 20.09 Billion INR | 17.506% |
| FDC Limited | 19.42 Billion INR | 14.696% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 85.97% |
| Granules India Limited | 45.06 Billion INR | 63.221% |
| Gufic Biosciences Limited | 8.06 Billion INR | -105.465% |
| Indoco Remedies Limited | 17.89 Billion INR | 7.378% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -29.395% |
| Ipca Laboratories Limited | 76.22 Billion INR | 78.256% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -694.154% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -3187.122% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -1488.552% |
| Laurus Labs Limited | 50.01 Billion INR | 66.864% |
| Mankind Pharma Limited | 103.34 Billion INR | 83.963% |
| Megasoft Limited | 373.95 Million INR | -4332.151% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -43.965% |
| Piramal Pharma Limited | 81.71 Billion INR | 79.716% |
| RPG Life Sciences Limited | 5.82 Billion INR | -184.755% |
| Sigachi Industries Limited | 3.98 Billion INR | -315.438% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -2093.937% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 96.582% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -57.646% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -539.327% |
| Windlas Biotech Limited | 6.3 Billion INR | -162.683% |
| ZIM Laboratories Limited | 3.67 Billion INR | -351.09% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 91.287% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -115.18% |
| Wanbury Limited | 5.75 Billion INR | -187.921% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -293.47% |
| Bal Pharma Limited | 3.39 Billion INR | -388.597% |
| Strides Pharma Science Limited | 40.51 Billion INR | 59.088% |
| Venus Remedies Limited | 5.91 Billion INR | -180.229% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 8.708% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 1.584% |
| Shilpa Medicare Limited | 11.51 Billion INR | -43.923% |
| Aarti Drugs Limited | 25.28 Billion INR | 34.453% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | 21.782% |
| Suven Life Sciences Limited | 116.92 Million INR | -14074.551% |
| Ind-Swift Limited | 5.02 Billion INR | -229.855% |
| Valiant Laboratories Limited | 1.82 Billion INR | -810.382% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | 52.43% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -33.836% |
| Themis Medicare Limited | 3.81 Billion INR | -334.15% |
| Hikal Limited | 17.84 Billion INR | 7.127% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 84.372% |
| Sequent Scientific Limited | 13.69 Billion INR | -21.003% |
| Novartis India Limited | 3.35 Billion INR | -394.648% |
| Wockhardt Limited | 27.89 Billion INR | 40.573% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 75.273% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -4039.887% |
| Neuland Laboratories Limited | 15.58 Billion INR | -6.341% |
| Morepen Laboratories Limited | 17.01 Billion INR | 2.614% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -973.647% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -349.658% |